D-NMAPPD structure
|
Common Name | D-NMAPPD | ||
|---|---|---|---|---|
| CAS Number | 35922-06-6 | Molecular Weight | 422.558 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 636.2±55.0 °C at 760 mmHg | |
| Molecular Formula | C23H38N2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 338.6±31.5 °C | |
Use of D-NMAPPDD-NMAPPD ((1R,2R)-B13) is an acid ceramidase inhibitor. D-NMAPPD regulates NMDA receptor properties by enhancing endogenous production of ceramides. D-NMAPPD has anticancer effecs[1][2]. |
| Name | (1r,2r)-b13 |
|---|---|
| Synonym | More Synonyms |
| Description | D-NMAPPD ((1R,2R)-B13) is an acid ceramidase inhibitor. D-NMAPPD regulates NMDA receptor properties by enhancing endogenous production of ceramides. D-NMAPPD has anticancer effecs[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | In rat hippocampal slices, D-NMAPPD exhibit increased N-methyl-D-aspartate (NMDA) receptor-mediated field excitatory postsynaptic potentials (fEPSPs) in CA1 synapses[1]. |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 636.2±55.0 °C at 760 mmHg |
| Molecular Formula | C23H38N2O5 |
| Molecular Weight | 422.558 |
| Flash Point | 338.6±31.5 °C |
| Exact Mass | 422.278076 |
| PSA | 115.38000 |
| LogP | 6.45 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.530 |
| InChIKey | XUSDVLHKNBOGJY-FYYLOGMGSA-N |
| SMILES | CCCCCCCCCCCCCC(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1 |
| N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]tetradecanamide |
| d-nmappd |
| N-[(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)-2-propanyl]tetradecanamide |
| Tetradecanamide, N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]- |